This prospective cohort study evaluated 107 urine samples from patients suspected of urinary tract infection (UTI) treated at Cajueiros General Hospital in Angola from January to March 2023. Inclusion criteria involved obtaining urine samples for clinical examinations from adult patients with suspected UTI, regardless of gender, age, or previous clinical condition. The samples were transported to the reference laboratory of the National Institute of Health Research for microbiological evaluation and antibiotic sensitivity testing using the VITEK 2 system. Of the 107 patients evaluated, 39.3% (n= 42) showed bacterial growth in their urine. Escherichia coli was the predominant pathogen (23.8%), followed by Sphingomonas paucimobilis, Pseudomonas luteola, and Klebsiella pneumoniae. Antimicrobial resistance was observed, with ampicillin (90.5%) being the most resistant, while imipenem (95.2%) and ertapenem (90.5%) exhibited high sensitivity. Statistical analysis revealed common clinical characteristics, such as fever (61.7%) and dysuria (73.8%). This study provides a comprehensive understanding of microbial ecology in urinary infections, highlighting the prevalence of pathogens and antibiotic resistance patterns in a specific patient population in Angola. Importantly, this research represents the first prospective study of its kind in Angola.
References
Pietropaolo A. Urinary Tract Infections: Prevention, Diagnosis, and Treatment. J Clin Med. 2023 Aug 1;12(15):5058. doi: 10.3390/jcm12155058. PMID: 37568460; PMCID: PMC10420219.
Huang L, Huang C, Yan Y, Sun L, Li H. Urinary Tract Infection Etiological Profiles and Antibiotic Resistance Patterns Varied Among Different Age Categories: A Retrospective Study From a Tertiary General Hospital During a 12-Year Period. Front Microbiol. 2022 Jan 27;12:813145.
Ciani O, Grassi D, Tarricone R. An economic perspective on urinary tract infection: the "costs of resignation". Clin Drug Investig. 2013 Apr;33(4):255-61. doi: 10.1007/s40261-013-0069-x. PMID: 23475540.
Zeng Z, Zhan J, Zhang K, Chen H, Cheng S. Global, regional, and national burden of urinary tract infections from 1990 to 2019: an analysis of the global burden of disease study 2019. World J Urol. 2022 Mar;40(3):755-763. doi: 10.1007/s00345-021-03913-0. Epub 2022 Jan 23. PMID: 35066637.
Keating KN, Perfetto EM, Subedi P. Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs. Expert Rev Pharmacoecon Outcomes Res. 2005 Aug;5(4):457-66. doi: 10.1586/14737167.5.4.457. PMID: 19807263.
Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front Public Health. 2022 Jul 27;10:888205. doi: 10.3389/fpubh.2022.888205. PMID: 35968451; PMCID: PMC9363895.
Schmider J, Bühler N, Mkwatta H, Lechleiter A, Mlaganile T, Utzinger J, Mzee T, Kazimoto T, Becker SL. Microbiological Characterisation of Community-Acquired Urinary Tract Infections in Bagamoyo, Tanzania: A Prospective Study. Trop Med Infect Dis. 2022 Jun 12;7(6):100. doi: 10.3390/tropicalmed7060100. PMID: 35736979; PMCID: PMC9228238.
Mukosha M, Nambela L, Mwila C, Chigunta M, Kalungia AC, Lubeya MK, Vwalika B. Urinary tract infections and associated factors in HIV infected pregnant women at a tertiary hospital in Lusaka, Zambia. Pan Afr Med J. 2020 Dec 8;37:328.
Waller TA, Pantin SAL, Yenior AL, Pujalte GGA. Urinary Tract Infection Antibiotic Resistance in the United States. Prim Care. 2018 Sep;45(3):455-466. doi: 10.1016/j.pop.2018.05.005. Epub 2018 Jul 9. PMID: 30115334.
Frimodt-Møller N, Bjerrum L. Treating urinary tract infections in the era of antibiotic resistance. Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(12):1301-1308. doi: 10.1080/14787210.2023.2279104. Epub 2023 Nov 24. PMID: 37922147.
Cooper E, Jones L, Joseph A, Allison R, Gold N, Larcombe J, Moore P, McNulty CAM. Diagnosis and Management of UTI in Primary Care Settings-A Qualitative Study to Inform a Diagnostic Quick Reference Tool for Women Under 65 Years. Anti-biotics (Basel). 2020 Sep 7;9(9):581. doi: 10.3390/antibiotics9090581. PMID: 32906671; PMCID: PMC7559568.
Butler CC, Hillier S, Roberts Z, Dunstan F, Howard A, Palmer S. Antibiotic-resistant infections in primary care are symp-tomatic for longer and increase workload: outcomes for patients with E. coli UTIs. Br J Gen Pract. 2006 Sep;56(530):686-92. PMID: 16954001; PMCID: PMC1876635.
Chin TL, McNulty C, Beck C, MacGowan A. Antimicrobial resistance surveillance in urinary tract infections in primary care. J Antimicrob Chemother. 2016 Oct;71(10):2723-8. doi: 10.1093/jac/dkw223. Epub 2016 Jun 26. PMID: 27353470.
Casey JA, Rudolph KE, Robinson SC, Bruxvoort K, Raphael E, Hong V, Pressman A, Morello-Frosch R, Wei RX, Tartof SY. Sociodemographic Inequalities in Urinary Tract Infection in 2 Large California Health Systems. Open Forum Infect Dis. 2021 May 26;8(6):ofab276. doi: 10.1093/ofid/ofab276. PMID: 34189179; PMCID: PMC8231389.
Zhen X, Chen J, Sun X, Sun Q, Guo S, Stålsby Lundborg C. Socioeconomic Factors Contributing to Antibiotic Resistance in China: A Panel Data Analysis. Antibiotics (Basel). 2021 Aug 17;10(8):994. doi: 10.3390/antibiotics10080994. PMID: 34439044; PMCID: PMC8388882.
Augusto WD, Paixão JPM da, Viveiros M, Nicolau S de M. Sensitivity profile of pathogens identified in the diagnosis of urinary infection by uroculture carried out at the National Institute for Health Research, Luanda/Angola, during the pre - pandemic, intra - pandemic and post - pandemic of COVID 19. Braz J Clin Med Rev. 9 de fevereiro de 2024;2(4):3–14.
Augusto, D. W. Infecção Urinária Causada por bacterias do gênero Klebsiella spp, Enterobacter spp, E. coli – Estudo labora-torial, 1a. Vol. 1o. Luanda: Bc Livtec; 2023. 86 p.